IntraBio announces US FDA accepts new dug application for IB1001 for the treatment of Niemann-Pick disease type C

IntraBio

26 March 2024 - PDUFA date set for 24 September 2024.

IntraBio today announced that the US FDA has accepted its new drug application for IB1001 for the treatment of Niemann-Pick disease type C.

Read IntraBio press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Submission